今日，临港新片区召开了2024年临港新片区重点企业“服务包”工作推进会，临港新片区党工委委员龚红兵、市经信委重点企业服务办（中小企业办）主任吴志琦出席会议并讲话，标新生物作为重点企业代表参加会议。
重点企业“服务包”制度是上海加强政企沟通、深化企业服务、优化营商环境的重要创新举措，通过常态走访联系、专人服务对接、政策量身定制，助力企业精准掌握政策、便利获取服务、高效办理需求，并依托政务服务“一网通办”设立“服务包”专窗平台，切实解决企业关心的突出问题。
会议举行了新增企业的服务包扩大仪式，临港新片区党工委委员龚红兵同志为标新生物发放了企业服务包及企业服务名牌。
本次标新生物作为重点企业获得临港新片区发放的服务包，充分证明了市领导对于市级重点企业发展的重视，标新生物将充分利用临港新片区提供的“服务包”政策优势，加强与政府部门的沟通合作，不断提升自身核心竞争力，为临港的高质量发展贡献力量。
Today, the Lingang New Area convened a promotion meeting for the 2024 "Service Package" program aimed at key enterprises in the New Area. Gong Hongbing, Member of the Lingang New Area Party Working Committee, and Wu Zhiqi, Director of the Key Enterprise Service Office (SME Office) of Shanghai Municipal Commission of Economy and Informatization, attended the meeting and delivered speeches. As a representative of key enterprises,Gluetacs Therapeutics participated in the meeting.
The "Service Package" system for key enterprises represents a significant innovative measure adopted by Shanghai to strengthen government-enterprise communication, deepen enterprise services, and optimize the business environment. By implementing regular visits, dedicated service teams, and tailored policies, it enables enterprises to precisely grasp policies, conveniently access services, and efficiently address their needs. Additionally, relying on the "One-Stop Service" for government affairs, a special window for the "Service Package" has been established to effectively resolve prominent issues of concern to enterprises.
The meeting featured an expansion ceremony for the service packages of newly added enterprises, where Gong Hongbing, a member of the Lingang New Area Party Working Committee, presented Gluetacswith a corporate service package and a corporate service nameplate.
Gluetacs' receipt of the service package from the Lingang New Area as a key enterprise underscores the municipal leader's emphasis on the development of key enterprises at the municipal level.Gluetacs will fully leverage the policy advantages offered by the "Service Package" in the Lingang New Area, strengthen communication and cooperation with government departments, continuously enhance its core competitiveness, and contribute to the high-quality development of Lingang.
关于标新生物
标新生物自成立以来受到业内的广泛关注，连续三年获得上海市科技型中小企业称号，荣获2024专精特新中小企业和创新型中小企业称号、2024年度临港新片区科创新锐企业称号、2023上海市高价值专利运营大赛百强、2023中国海归创业大赛三等奖、2023华医榜中国生物医药科技创新价值榜最具成长性小分子创新药企业TOP10、2023临港杯第九届创青春上海青年创新创业大赛一等奖、2022浦东新区全球高校校友科创大赛二等奖，2022中国创新制药企业TOP10、2022第十一届中国创新创业大赛成长组全国赛优秀企业奖、2022第6届医疗健康投资卓悦榜年度生物医药最佳企业、2022第五届中国创翼创业创新大赛上海选拔赛浦东赛区十佳创翼奖、2022浦东新区全球高校校友科创大赛二等奖、2022Venture50新芽榜150强、2021年度全国颠覆性技术创新大赛优秀项目、2021年第二届生物产业年度攀登榜年度最具投资潜质的新锐BioTech、2021中国生物医药产业链创新风云榜金马奖最具关注度新锐企业TOP10奖项。公司陆续获得多项科技部和上海市科委资金支持，纳入临港新片区前沿产业优秀人才安家补贴、重点产业人才补贴、人才引进重点机构名单，知识产权管理体系获得中国专利保护协会认证，多位团队核心成员陆续获得临港新片区十大科技创新先锋人物、谈家桢生命科学产业化奖、杨雄科技创业奖、东方英才创业青年领军人才、上海高层次海外人才和上海市浦江人才等称号。公司也先后成为上海科技大学创新型硕士和工程博士培养单位，并先后与十多位海内外专家教授进行科研研究合作。
来源：临港新片区投资促进服务中心
